Related Experiment Video
Updated: Apr 26, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
The Axin2 rs2240308 polymorphism and susceptibility to lung cancer in a Chinese population
Dan Liu1, Ling Li, Yuguang Yang
1Department of Medical Oncology, Cancer Hospital of Harbin Medical University, No. 150, Haping Road, Nangang, 150081, Harbin, China.
Abstract:
Axis inhibition protein 2 (Axin2) is a negative regulator of the canonical Wnt/β-catenin signaling pathway, and functions as a tumor suppressor in a number of human cancers. Previous pilot studies have suggested an association between Axin2 exon1 148 (rs2240308) SNP polymorphism and risk for lung cancer. In the present study, we aimed to investigate the Axin2 exon1 148 polymorphism and its association with lung cancer susceptibility in Han Chinese population. The Axin2 exon1 148 SNP was genotyped in 555 controls and 520 lung cancer patients using TaqMan SNP Genotyping Assays. Unconditional logistic regression analysis was used to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs). We observed that the genotype frequencies of TC, TT, and CC were significantly different between controls and cases (χ(2) = 6.849, P = 0.03256, df = 2). Subjects carrying T allele (TC + TT genotypes) had decreased susceptibility to lung cancer as compared to those carrying CC genotype (OR = 0.733, 95% CI = 0.5726-0.9393, P = 0.01382). No significant association was found between rs2240308 polymorphism and histological subtypes of lung cancers. Findings from this study suggest that Axin2 exon1 T148C polymorphism (rs2240308) contributes to increased susceptibility to lung cancer in Chinese population. This further implicates Axin2 as a lung cancer-related gene.
Insights
The Axin2 exon1 T148C polymorphism (rs2240308) is linked to lung cancer risk in the Chinese population. Carrying the T allele may decrease susceptibility to lung cancer.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Axis inhibition protein 2 (Axin2) is a key negative regulator of the Wnt/β-catenin pathway.
- Axin2 functions as a tumor suppressor in various human cancers.
- Prior studies suggested a link between Axin2 exon1 148 (rs2240308) SNP and lung cancer risk.
Purpose of the Study:
- To investigate the association between the Axin2 exon1 148 (rs2240308) polymorphism and lung cancer susceptibility.
- To analyze the role of this polymorphism in the Han Chinese population.
Main Methods:
- Genotyping of the Axin2 exon1 148 SNP (rs2240308) using TaqMan assays.
- Study included 555 controls and 520 lung cancer patients.
- Unconditional logistic regression analysis was employed to calculate odds ratios (ORs) and 95% confidence intervals (CIs).
Main Results:
- Significant differences in genotype frequencies (TC, TT, CC) were observed between lung cancer cases and controls (χ(2)=6.849, P=0.03256).
- Individuals with the T allele (TC + TT genotypes) showed decreased lung cancer susceptibility compared to the CC genotype (OR=0.733, P=0.01382).
- No significant association was found between the rs2240308 polymorphism and lung cancer histological subtypes.
Conclusions:
- The Axin2 exon1 T148C polymorphism (rs2240308) is associated with altered lung cancer susceptibility in the Chinese population.
- This finding reinforces the role of Axin2 as a gene implicated in lung cancer development.
- The T allele may confer a protective effect against lung cancer in this population.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pleiotropy

